The Journal of Immunology · 2013 · 47 citations · 41 references
Life SciencesCell BiologyImmunologyCancer ImmunologyCellular ImmunologyImmunotherapyAdaptive Immune ResponsesCancer ImmunotherapyCancer VaccinesCell-mediated ImmunityDendritic Cell BiologyImmunological MemoryCellular Immune MemoryDendritic Cell SignalingDendritic Cell-t Cell InteractionMemory T Cell Responses To TumorsMemory T-cell FormationPlasmacytoid Dendritic Cell ResponsesTumor Antigen Cross-presentationVaccine-induced Immune Memory
A key goal of vaccine immunotherapy is the generation of long-term memory CD8(+) T cells capable of mediating immune surveillance. We discovered a novel intercellular pathway governing the development of potent memory CD8(+) T cell responses against cell-associated Ags that is mediated through cross-presentation by XCR1(+) dendritic cells (DCs). Generation of CD8(+) memory T cells against tumor cells pulsed with an invariant NKT cell ligand depended on cross-talk between XCR1(+) and plasmacytoid DCs that was regulated by IFN-α/IFN-αR signals. IFN-α production by plasmacytoid DCs was stimulated by an OX40 signal from the invariant NKT cells, as well as an HMGB1 signal from the dying tumor cells. These findings reveal a previously unknown pathway of intercellular collaboration for the generation of tumor-specific CD8(+) memory T cells that can be exploited for strategic vaccination in the setting of tumor immunotherapy.
41
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Stephen P. Schoenberger, René E. M. Toes, Ellen I. H. van der Voort et al. · Nature · 1998 · 2.6K citations
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Kenya Honda, Hideyuki Yanai, Hideo Negishi et al. · Nature · 2005 · 2.2K citations
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Andrew M. Intlekofer, Naofumi Takemoto, E. John Wherry et al. · Nature Immunology · 2005 · 1.2K citations